JAZZ - Jazz Pharmaceuticals names Philip Johnson as CFO
2024-02-21 08:05:31 ET
More on Jazz Pharmaceuticals
- Updated View On Jazz Pharmaceuticals' 2025 Goals
- Jazz Pharmaceuticals' Zanidatamab Promises Growth Amidst Market Undervaluation
- Baupost Group steps away from Atara, Veritiv; bulks up on Clarivate, Jazz Pharma
- Jazz Pharmaceuticals to buy global rights to KRAS inhibitor program
- Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals